Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Infective Endocarditis
88%
Endocarditis
35%
Patient Characteristics
26%
Study Registry
26%
Bacteremia
18%
Positron Emission Tomography/computed Tomography (PET/CT)
15%
Left-handed
14%
National Cohort Study
13%
Left-sided Infective Endocarditis
13%
1-year Mortality
13%
Heart Valve Prosthesis
12%
Temporal Trends
12%
Prognostic Importance
12%
DOTATATE
12%
Staphylococcus
11%
Comorbidity
10%
Prosthetic Valve Endocarditis
10%
Valve Surgery
9%
Clinical Outcomes
9%
Native Valve Endocarditis
8%
In-hospital Mortality
7%
Nationwide Data
7%
Long-term Mortality
7%
Clinical Characteristics
7%
Surgical Treatment
6%
Indications for Surgery
6%
Bacterial Species
6%
Culture-negative Endocarditis
6%
Nidus
6%
Clinical Practice
6%
Type 2 Diabetes Mellitus (T2DM)
6%
Coronary Artery Pathology
6%
Frailty
6%
Albuminuria
6%
Early Surgery
6%
Antibiotic Therapy
6%
Accessory Atrioventricular Pathway
6%
Heart Valve Surgery
6%
Transcatheter Aortic Valve Implantation
6%
18F-fluorodeoxyglucose (18F-FDG)
6%
Head-to-head Comparison
6%
Overall Mortality
6%
Microorganisms
6%
Background Population
6%
Characteristic Importance
6%
Clinical Treatment
6%
Genome-wide Association Study
6%
First-in-human
6%
Atrioventricular
6%
Dialysis
6%
Medicine and Dentistry
Infective Endocarditis
100%
Endocarditis
38%
Patient Characteristics
30%
Cohort Analysis
18%
Positron Emission Tomography-Computed Tomography
14%
Heart Valve Prosthesis
13%
Copper 64
13%
Staphylococcus Aureus
12%
Bloodstream Infection
12%
Percutaneous Aortic Valve Replacement
12%
Prosthetic Valve Endocarditis
10%
Comorbidity
9%
Hospital Mortality
9%
Fluorodeoxyglucose F 18
8%
Etiology
7%
Surgery
6%
Antibiotic Therapy
6%
Maturity Onset Diabetes of the Young
6%
Frailty
6%
Albuminuria
6%
Coronary Artery
6%
Heart Valve Surgery
6%
Human Study
6%
Long Term Survival
6%
Diabetes Mellitus
6%
Heart Accessory Conduction Pathway
6%
